IceCure Medical CEO reports 405K-unit stock grant

As of November 2, 2026, Eyal Shamir's direct holdings included 428,685 RSUs, with 9,862 vested.

Available on EDGAR 11/02/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

On November 2, 2026, Eyal Shamir, IceCure Medical Ltd.'s Chief Executive Officer and director, reported an award of 404,901 restricted share units (RSUs), granted August 11, 2026. Twenty-five percent vest on August 11, 2027; the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter.

As of November 2, 2026, his direct holdings included 2,596 ordinary shares and 428,685 RSUs, of which 9,862 were vested and 418,823 remained unvested. The holdings were adjusted to reflect the issuer's 1-for-30 reverse share split effected June 4, 2026.

Insider Trade Summary

Grant/Award: 404,901 shares

Grant/Award 1 txn

Insider Shamir Eyal

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1, F2	404,901	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 431,281 shares (Direct)

Footnotes (2)

1. F1. Represents 404,901 restricted share units ("RSUs") granted on August 11, 2026, 25% of which vest on August 11, 2027 and the remaining 75% of which vest in twelve equal quarterly installments of 6.25% thereafter.
2. F2. Represents (i) 2,596 ordinary shares and (ii) 428,685 RSUs (including the RSUs described in Footnote 1 above), of which 9,862 have vested and 418,823 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

Key Figures

RSUs awarded: 404,901 RSUs First vesting portion: 25% Quarterly vesting: 12 installments of 6.25% each +4 more

7 metrics

RSUs awarded 404,901 RSUs Grant dated August 11, 2026

First vesting portion 25% Vests August 11, 2027

Quarterly vesting 12 installments of 6.25% each Remaining RSUs vest in equal quarterly installments

RSUs held 428,685 RSUs Direct holdings as of November 2, 2026

Vested RSUs 9,862 RSUs As of November 2, 2026

Unvested RSUs 418,823 RSUs As of November 2, 2026

Ordinary shares held 2,596 ordinary shares Direct holdings as of November 2, 2026

Key Terms

restricted share units, vest, reverse share split

3 terms

restricted share units financial

"the award of 404,901 restricted share units (RSUs)"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

vest financial

"25% of which vest on August 11, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

reverse share split financial

"the Issuer's 1-for-30 reverse share split"

A reverse share split is when a company reduces the number of its shares outstanding by combining multiple shares into one, effectively increasing the price of each share. For investors, this can help improve the company's image or meet stock exchange listing requirements, but it does not change the total value of their investment. It’s similar to turning many small pieces of a puzzle into fewer larger pieces—nothing new is added or lost, just rearranged.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did ICCM CEO Eyal Shamir receive?

Eyal Shamir's reported award was 404,901 RSUs, granted August 11, 2026. Twenty-five percent vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter.

How many of Eyal Shamir's ICCM RSUs were vested?

As of November 2, 2026, 9,862 of his 428,685 RSUs were vested, while 418,823 remained unvested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shamir Eyal

(Last) (First) (Middle)

7 HA'ESHEL ST., PO BOX 3163

(Street)

CAESAREA 3079504

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
IceCure Medical Ltd. [ ICCM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/02/2026		A		404,901(1)	A	$0	431,281(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 404,901 restricted share units ("RSUs") granted on August 11, 2026, 25% of which vest on August 11, 2027 and the remaining 75% of which vest in twelve equal quarterly installments of 6.25% thereafter.

2. Represents (i) 2,596 ordinary shares and (ii) 428,685 RSUs (including the RSUs described in Footnote 1 above), of which 9,862 have vested and 418,823 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

	/s/ Eyal Shamir	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)